Similarly, Tau-negative expression has been related to a favorable response to Paclitaxel treatment in gastric (Mimori et al., 2006; Wang et al., 2013; He et al., 2014; Yu et al., 2014) and bladder cancer (Wosnitzer et al., 2011). This evidence concerns the gene MAPT and urinary bladder cancer.